$BAYRY news
The latest BAYRY stock news: headlines, filings, AI summaries and sentiment for $BAYRY, updated around the clock.
- FDA Approves Bayer's Asundexian for Secondary Stroke Prevention
- Regeneron Reports Strong Q3 2026 Results Driven by Sanofi Collaboration and Libtayo Growth
- BridgeBio Pharma Reports Strong Q3 2026 Revenue Growth Driven by Attruby Expansion
- Sopris Capital Acquires Blackford Analysis to Enhance HealthTech Portfolio
- Corteva Shares Rise Over 12% on JPMorgan Upgrade Post-Spinoff
- ORIC Initiates Phase 3 Trial for Prostate Cancer Drug Rinzimetostat
- Healthcare Sector Headlines: Merck, AbbVie, and Bayer in Focus
- Supreme Court Limits Roundup Cancer Lawsuits Against Bayer's Monsanto